BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24857502)

  • 1. Enhanced gastric tolerability and improved anti-obesity effect of capsaicinoids-loaded PCL microparticles.
    Almeida MA; Nadal JM; Grassiolli S; Paludo KS; Zawadzki SF; Cruz L; Paula JP; Farago PV
    Mater Sci Eng C Mater Biol Appl; 2014 Jul; 40():345-56. PubMed ID: 24857502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: preparation, characterization and in vivo evaluation in rats.
    Ghorab DM; Amin MM; Khowessah OM; Tadros MI
    Drug Deliv; 2011; 18(7):523-35. PubMed ID: 21793779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapalene-loaded poly(ε-caprolactone) microparticles: Physicochemical characterization and in vitro penetration by photoacoustic spectroscopy.
    Nadal JM; Dos Anjos Camargo G; Novatski A; Macenhan WR; Dias DT; Barboza FM; Lyra A; Roik JR; Padilha de Paula J; Somer A; Farago PV
    PLoS One; 2019; 14(3):e0213625. PubMed ID: 30897170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.
    Diab R; Hamoudeh M; Boyron O; Elaissari A; Fessi H
    Drug Dev Ind Pharm; 2010 Apr; 36(4):456-69. PubMed ID: 19877831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCL/PHBV microparticles as innovative carriers for oral controlled release of manidipine dihydrochloride.
    Barboza FM; Machado WM; Olchanheski Junior LR; Padilha de Paula J; Zawadzki SF; Fernandes D; Farago PV
    ScientificWorldJournal; 2014; 2014():268107. PubMed ID: 24550699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.
    Dorati R; Genta I; Colzani B; Tripodo G; Conti B
    Drug Dev Ind Pharm; 2015; 41(7):1182-92. PubMed ID: 24994001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats.
    Cruz L; Assumpção E; Andrade SF; Conrado DJ; Kulkamp IC; Guterres SS; Pohlmann AR
    Eur J Pharm Sci; 2010 Aug; 40(5):441-7. PubMed ID: 20471479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion Processes and Drug Release: Capsaicinoids - Loaded Poly (ε-caprolactone) Microparticles.
    Lenzi EK; Novatski A; Farago PV; Almeida MA; Zawadzki SF; Menechini Neto R
    PLoS One; 2016; 11(6):e0157662. PubMed ID: 27309358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ε-caprolactone), Eudragit® RS 100 and poly(ε-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz.
    Seremeta KP; Chiappetta DA; Sosnik A
    Colloids Surf B Biointerfaces; 2013 Feb; 102():441-9. PubMed ID: 23010128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes.
    Mendes JB; Riekes MK; de Oliveira VM; Michel MD; Stulzer HK; Khalil NM; Zawadzki SF; Mainardes RM; Farago PV
    ScientificWorldJournal; 2012; 2012():542937. PubMed ID: 22666135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of crystalline microstructure on drug release behavior of poly(epsilon-caprolactone) microspheres.
    Jeong JC; Lee J; Cho K
    J Control Release; 2003 Oct; 92(3):249-58. PubMed ID: 14568406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticles.
    Rodrigues MR; Lanzarini CM; Ricci-Junior E
    Pharm Dev Technol; 2011 Feb; 16(1):12-21. PubMed ID: 20001271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: development, characterization and in vitro evaluation of their antitumoral efficacy.
    Hernán Pérez de la Ossa D; Ligresti A; Gil-Alegre ME; Aberturas MR; Molpeceres J; Di Marzo V; Torres Suárez AI
    J Control Release; 2012 Aug; 161(3):927-32. PubMed ID: 22580111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of starch-poly-epsilon-caprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications.
    Balmayor ER; Tuzlakoglu K; Azevedo HS; Reis RL
    Acta Biomater; 2009 May; 5(4):1035-45. PubMed ID: 19095509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterizations, in vitro and in vivo evaluation of Etoricoxib-loaded Poly (Caprolactone) microparticles--a potential Intra-articular drug delivery system for the treatment of Osteoarthritis.
    Arunkumar P; Indulekha S; Vijayalakshmi S; Srivastava R
    J Biomater Sci Polym Ed; 2016; 27(4):303-16. PubMed ID: 26689653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composite microparticles with in vivo reduction of the burst release effect.
    Sheikh Hassan A; Sapin A; Lamprecht A; Emond E; El Ghazouani F; Maincent P
    Eur J Pharm Biopharm; 2009 Nov; 73(3):337-44. PubMed ID: 19651210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release behaviour of carbamazepine-loaded poly(ε-caprolactone)/poly(ethylene oxide) microspheres.
    Pepic D; Nikolic MS; Grujic S; Lausevic M; Djonlagic J
    J Microencapsul; 2013; 30(2):151-60. PubMed ID: 22852775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
    Wei X; Gong C; Shi S; Fu S; Men K; Zeng S; Zheng X; Gou M; Chen L; Qiu L; Qian Z
    Int J Pharm; 2009 Mar; 369(1-2):170-5. PubMed ID: 19028556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics.
    Karataş A; Sonakin O; Kiliçarslan M; Baykara T
    J Microencapsul; 2009 Feb; 26(1):63-74. PubMed ID: 18608798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and release profiles of MPEG-PCL-MPEG microspheres containing immunoglobulin G.
    Erdemli Ö; Usanmaz A; Keskin D; Tezcaner A
    Colloids Surf B Biointerfaces; 2014 May; 117():487-96. PubMed ID: 24530344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.